This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Lactobacillus gasseri is a bacterial culture indicated to treat fluorine vaginalis.
- Generic Name
- Lactobacillus gasseri
- DrugBank Accession Number
- DB16543
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- L. gasseri
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Vaginal flora imbalance ••• ••• ••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image OraBalance Breathcare Lactobacillus gasseri (56 mg/100g) + Lactobacillus fermentum (24 mg/100g) Tablet Dental isamogu Inc. 2022-08-02 Not applicable US 
OraBalance dentalcare Lactobacillus gasseri (24 mg/100g) + Lactobacillus fermentum (72 mg/100g) Tablet Dental isamogu Inc. 2022-07-13 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image OraBalance Breathcare Lactobacillus gasseri (56 mg/100g) + Lactobacillus fermentum (24 mg/100g) Tablet Dental isamogu Inc. 2022-08-02 Not applicable US OraBalance dentalcare Lactobacillus gasseri (24 mg/100g) + Lactobacillus fermentum (72 mg/100g) Tablet Dental isamogu Inc. 2022-07-13 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Q66E0D2443
- CAS number
- Not Available
References
- General References
- BASG: Döderlein Med (Lactobacillus gasseri) Vaginal Capsule [Link]
- External Links
- 2462497
- Wikipedia
- Lactobacillus_gasseri
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Recruiting Treatment Opioid Induced Constipation (OIC) 1 Not Available Completed Treatment Vulvovaginal Candidiasis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Vaginal Tablet Dental - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 03, 2021 16:31 / Updated at May 05, 2021 20:32